| TSBP1-AS1 |
|
TSBP1 and BTNL2 antisense RNA 1
|
|
|
0.638 |
0.692 |
| ZNRD1ASP |
|
zinc ribbon domain containing 1 antisense, pseudogene
|
|
|
0.691 |
0.538 |
| LINC02571 |
|
long intergenic non-protein coding RNA 2571
|
|
|
0.743 |
0.500 |
| HCG18 |
|
HLA complex group 18
|
|
|
0.722 |
0.538 |
| LINC00243 |
|
long intergenic non-protein coding RNA 243
|
|
|
0.729 |
0.423 |
| SPRY4-AS1 |
|
SPRY4 antisense RNA 1
|
|
|
0.890 |
0.192 |
| HCG17 |
|
HLA complex group 17
|
|
|
0.769 |
0.346 |
| PSORS1C3 |
|
psoriasis susceptibility 1 candidate 3
|
|
|
0.769 |
0.269 |
| ATP6V1G2-DDX39B |
|
ATP6V1G2-DDX39B readthrough (NMD candidate)
|
|
|
0.769 |
0.423 |
| HCG27 |
|
HLA complex group 27
|
|
2.3E-02 |
0.805 |
0.346 |
| SNHG32 |
|
small nucleolar RNA host gene 32
|
|
2.4E-02 |
0.805 |
0.308 |
| USP8P1 |
|
USP8 pseudogene 1
|
|
|
0.805 |
0.269 |
| LINC01150 |
|
long intergenic non-protein coding RNA 1150
|
|
|
0.931 |
0.038 |
| DISC1FP1 |
|
DISC1 fusion partner 1
|
|
|
0.931 |
0.038 |
| SLC2A1-AS1 |
|
SLC2A1 antisense RNA 1
|
|
|
1.000 |
|
| LINC00298 |
|
long intergenic non-protein coding RNA 298
|
|
|
0.861 |
0.038 |
| NBPF13P |
|
NBPF member 13, pseudogene
|
|
|
0.890 |
0.038 |
| LINC02251 |
|
long intergenic non-protein coding RNA 2251
|
|
|
1.000 |
|
| SNORA38 |
|
small nucleolar RNA, H/ACA box 38
|
|
|
0.890 |
0.154 |
| LINC00836 |
|
long intergenic non-protein coding RNA 836
|
|
|
1.000 |
|
| LINC02748 |
|
long intergenic non-protein coding RNA 2748
|
|
|
1.000 |
|
| LINC00937 |
|
long intergenic non-protein coding RNA 937
|
|
|
1.000 |
|
| LINC02477 |
|
long intergenic non-protein coding RNA 2477
|
|
|
1.000 |
|
| TRAV30 |
A0A087WSZ9
|
T cell receptor alpha variable 30
|
|
|
0.861 |
0.038 |
| ZBTB7C |
A1YPR0
|
zinc finger and BTB domain containing 7C
|
|
0.16 |
0.691 |
0.577 |